Colleen S. Curran

Also affiliated with National Heart Lung and Blood Institute, New England Organ Bank

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “COVID-19 Usurps Host Regulatory Networks”.

COVID-19 Usurps Host Regulatory Networks

Frontiers in Pharmacology(2020)10.3389/fphar.2020.01278

N/A

0DataRank · unranked

31 citations

Donna R. Rivera, Jeffrey B. Kopp, Colleen S. Curran

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

UNC Libraries(2020)10.17615/zcrb-7g26

N/A

0DataRank · unranked

0 citations

Michael J. González, Samira A. Brooks, Laetitia Gonzalez, Venkata Sabbisetti, Judith Weisz +95 more

PD-1 immunobiology in glomerulonephritis and renal cell carcinoma

BMC Nephrology(2021)10.1186/s12882-021-02257-6

N/A

0DataRank · unranked

30 citations

Jeffrey B. Kopp, Colleen S. Curran

Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease

Frontiers in Pharmacology(2022)10.3389/fphar.2022.782199

N/A

0DataRank · unranked

35 citations

Jeffrey B. Kopp, Colleen S. Curran

RAGE pathway activation and function in chronic kidney disease and COVID-19

Frontiers in Medicine(2022)10.3389/fmed.2022.970423

N/A

0DataRank · unranked

30 citations

Jeffrey B. Kopp, Colleen S. Curran

The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease

Journal of Translational Medicine(2023)10.1186/s12967-023-04584-8

N/A

0DataRank · unranked

17 citations

Jeffrey B. Kopp, Colleen S. Curran

Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss

American Journal of Physiology-Lung Cellular and Molecular Physiology(2023)10.1152/ajplung.00171.2022

N/A

0DataRank · unranked

24 citations

Li‐Yuan Chen, Keytam S. Awad, Gabriela A. Ferreyra, Cumhur Y. Demirkale, Ali Keshavarz +12 more

Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages

The Journal of Immunology(2023)10.4049/jimmunol.2200552

N/A

0DataRank · unranked

11 citations

Edward J. Dougherty, Xizhong Cui, Yan Li, Mark Jeakle, T. Gamble +3 more

Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model

Frontiers in Immunology(2024)10.3389/fimmu.2023.1308358

N/A

0DataRank · unranked

3 citations

Xizhong Cui, Yan Li, Mark Jeakle, Junfeng Sun, Cumhur Y. Demirkale +9 more

Plasmalogens as biomarkers and therapeutic targets

Journal of Lipid Research(2025)10.1016/j.jlr.2025.100925

N/A

0DataRank · unranked

4 citations

Alan T. Remaley, Parizad Torabi‐Parizi, Colleen S. Curran

Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant models

Scientific Reports(2025)10.1038/s41598-025-95735-y

N/A

0DataRank · unranked

3 citations

Xizhong Cui, Yan Li, T. Gamble, Junfeng Sun, Samuel Minkove +4 more